Page 6 - 202018

Efficacy and Safety of Calcitonin Gene-related Peptide Monoclonal Antibodies in the Preventive Treatment of
Migraine：A Bayesian Network Meta-analysis ……………………………………………………………………
………… LIU Xin，ZHONG Xiaoyan，LI Mengya，XU Changjing，FU Liya，TIAN Dongmei，HUANG Yilan（2275）
Evaluation of the Risk of Medical Staff Occupationally Exposed to Antineoplastic Drugs in PIVAS of Our Hos-
pital Based on Biological Indicators ……… HU Xiaogang，ZHANG Xiaohua，CHEN Kaijie，LIU Ling，LI Na（2283）
Evaluation of Anticoagulant Effects of Clinical Pharmacist Management in Anticoagulation Clinic ………………
…………… LI Shuyue，HUI Xiang，JIN Yuanxiang，WANG Juan，ZHANG Huan，WANG Baoyan，XU Hang（2289）

CHINA PHARMACY （Semimonthly） Postal Address
Founded in January 1990 129 Daping Main Street，Yuzhong District，Chongqing
Vol.31，No.18，Sept. 2020 400042，China
Total No.684 Published on Sept. 30，2020 Phone
Responsible Institution 86-23-63830521；86-23-63830907
National Health Commission，P.R. China E-mail
Sponsored by info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Edited by Online Submission
China Pharmacy Editorial and Publishing Center http：//2018.china-pharmacy.com
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Honorary Editor-in-Chief Overseas：China International Book Trading Corporation
MA Jin （Code No.4703SM）
Editor-in-Chief Subscription Rates
HU Xin US $ 8.00 per issue；US $ 192.00 per annum
Vice Editor-in-Chief CSSN ISSN 1001-0408
LENG Huaiming CN 50-1055/R
Chief Editor CODEN
ZHANG Jian ZYHAA4
Published by Perennial Legal Counsel
China Pharmacy Editorial Department Chongqing Huali Wantao Law Firm